Boundless Capital Lease Obligations from 2010 to 2024
| BOLD Stock | USD 2.69 0.14 5.49% |
Capital Lease Obligations | First Reported 2010-12-31 | Previous Quarter 2.2 M | Current Value 2.8 M | Quarterly Volatility 1.4 M |
Check Boundless Bio, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boundless Bio,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 909.1 K, Selling General Administrative of 11.5 M or Other Operating Expenses of 55.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Boundless financial statements analysis is a perfect complement when working with Boundless Bio, Valuation or Volatility modules.
Boundless | Capital Lease Obligations |
Latest Boundless Bio,'s Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Boundless Bio, Common over the last few years. Boundless Bio, Common capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Boundless Bio, asset purchases. For example, Boundless Bio, can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Boundless Bio, control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Boundless Bio,'s Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boundless Bio,'s overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
Boundless Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 983,033 | |
| Geometric Mean | 577,738 | |
| Coefficient Of Variation | 141.21 | |
| Mean Deviation | 969,653 | |
| Median | 377,000 | |
| Standard Deviation | 1,388,145 | |
| Sample Variance | 1.9T | |
| Range | 4.8M | |
| R-Value | 0.60 | |
| Mean Square Error | 1.3T | |
| R-Squared | 0.36 | |
| Significance | 0.02 | |
| Slope | 186,441 | |
| Total Sum of Squares | 27T |
Boundless Capital Lease Obligations History
About Boundless Bio, Financial Statements
Boundless Bio, stakeholders use historical fundamental indicators, such as Boundless Bio,'s Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Although Boundless Bio, investors may analyze each financial statement separately, they are all interrelated. For example, changes in Boundless Bio,'s assets and liabilities are reflected in the revenues and expenses on Boundless Bio,'s income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Boundless Bio, Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 2.2 M | 2.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| NVDA | NVIDIA | |
| CRESY | Cresud SACIF y | |
| GOOG | Alphabet Inc Class C |
Check out the analysis of Boundless Bio, Correlation against competitors. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.